EU research in emerging and reemerging infectious diseases
Emerging and Re-Emerging Infectious Diseases (EIDs) are infections that have newly appeared in a population or have existed previously but are rapidly increasing in incidence or geographic range.
Examples include HIV/AIDS, variant Creutzfeld-Jacobs disease (vCJD) and SARS as well as reemerging diseases such as chikungunya, and influenza.
Research on emerging infectious diseases has been included in the Commission framework programmes for research since their inception.
HIV projects have been funded as early as 1985 in the first framework programme and the emergence of vCJD in the mid 1990s triggered a substantial research effort on transmissible spongiform encephalopathies (TSEs) starting from FP4 until today in both the food safety as well as the human health programmes.
Research in this area continues under Horizon 2020, the current research and innovation framework programme.
Neglected no more – Research on neglected infectious diseases (NID factsheet)
Funding for health under the research and innovation framework programme, Horizon Europe
Projects and results
EU-funded projects (CORDIS)
Projects in the field of emerging diseases on the Commission's primary portal for results of EU-funded research projects
Project success stories
Stories of particularly successful EU-funded research projects
Horizon Results Platform
Platform where framework programme funding recipients present their results to search, contact their owners and form partnerships
Collaboration and jobs
Find project partners
Look for project partners and view profiles of all organisations that have received funding via the funding and tender opportunities portal
Researcher jobs in related fields
Scientific publications, tools and databases
Horizon 2020 dashboard
Interactive reporting platform, composed of a set of sheets that allows series of views to discover and filter Horizon 2020 data
Scientific publications produced by the European Commission (JRC)
The European Commission and the Bill & Melinda Gates Foundation progress research cooperation to combat infectious diseases in Africa
EUR 55 million will be jointly invested for advancing genomic epidemiology in sub-Saharan Africa
EU and CEPI to provide funding for the development of a vaccine against Rift Valley fever
Research and innovation news alert: €35 million in financial support will be provided by Horizon Europe, the EU’s research and innovation programme, and up to €50 million in total will be made available by CEPI